Adalimumab vs. Conventional Immunosuppression for Uveitis (ADVISE) Trial. Jabs DA, Sugar EA, Burke AE, Altaweel M, et al. Ophthalmology 2025 Oct 10:S0161-6420(25)00639.

Read + Share

Amedeo Smart

Independent Medical Education

Jabs DA, Sugar EA, Burke AE, Altaweel M, et al. Adalimumab vs. Conventional Immunosuppression for Uveitis (ADVISE) Trial. Ophthalmology 2025 Oct 10:S0161-6420(25)00639.
PMID: 41077357